Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
Lefebvre M, Secher S, Bouchez S, Vandamme YM, Fialaire P, Leautez S, Blanchi S, Michau C, Coste-Burel M, Brunet-Cartier C, Reliquet V, Gregoire A, Raffi F, Allavena C; on behalf of the VIHStaRouge study group. Lefebvre M, et al. Among authors: gregoire a. AIDS. 2022 Jul 15;36(9):1273-1278. doi: 10.1097/QAD.0000000000003220. Epub 2022 Mar 7. AIDS. 2022. PMID: 35262533
Sport and self-esteem in people living with HIV: a cross-sectional study.
Grandiere Perez L, Allavena C, Sécher S, Durand S, Grégoire A, Vandamme YM, Hitoto H, Leautez-Nainville S, Michau C, Billaud E. Grandiere Perez L, et al. Among authors: gregoire a. BMC Infect Dis. 2022 Nov 17;22(1):858. doi: 10.1186/s12879-022-07860-y. BMC Infect Dis. 2022. PMID: 36396982 Free PMC article.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial.
Tamarelle J, Penaud B, Tyssandier B, Guichoux E, de Barbeyrac B, Peuchant O; Chlazidoxy study group. Tamarelle J, et al. Clin Microbiol Infect. 2023 Aug;29(8):1056-1062. doi: 10.1016/j.cmi.2023.04.020. Epub 2023 Apr 24. Clin Microbiol Infect. 2023. PMID: 37100225 Clinical Trial.
Doxycycline versus azithromycin for the treatment of anorectal Chlamydia trachomatis infection in women concurrent with vaginal infection (CHLAZIDOXY study): a multicentre, open-label, randomised, controlled, superiority trial.
Peuchant O, Lhomme E, Martinet P, Grob A, Baïta D, Bernier C, Gibaud SA, Le Hen I, Le Naour E, Trignol-Viguier N, Lanotte P, Lefebvre P, Vachée A, Girard T, Loubinoux J, Bébéar C, Ghezzoul B, Roussillon C, Kret M, de Barbeyrac B; CHLAZIDOXY Study Group. Peuchant O, et al. Lancet Infect Dis. 2022 Aug;22(8):1221-1230. doi: 10.1016/S1473-3099(22)00148-7. Epub 2022 May 9. Lancet Infect Dis. 2022. PMID: 35550262 Clinical Trial.